We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published On : Sep 2022
  • Code : CMI4631
  • Pages :205
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Electroporation is the microbiology technique that uses an electrical pulse to create temporary pores in cell membranes through which substances such as nucleic acids can pass into cells. Electroporation can be used for all cell types including mammalian, bacteria, algae, plant, and yeast. It uses an accurately pulsed electrical current to create temporary pores in the cell membrane through which the molecules can then pass. Some applications of electroporation include, Deoxyribonucleic acid transfection or transformation, direct transfer of plasmids between cells, induced cell fusion, trans-dermal drug delivery, and cancer tumor electro chemotherapy and gene therapy

Global electroporation instrument market is estimated to be valued at US$ 232.19 Mn in 2022 and is expected to reach US$ 328.53 Mn by 2030, exhibiting a CAGR of 4.4% during the forecast period (2022-2030).

Figure 1. Global Electroporation Instruments Market (%) in Terms of Value, By Region, 2022

ELECTROPORATION INSTRUMENTS MARKET

To learn more about this report, request a free sample copy

Increasing prevalence of cancer is the major factor that is expected to drive growth of the global electroporation instruments market over the forecast period.

Increasing prevalence of cancer, is the major factor that is expected to drive growth of the global electroporation instruments market over the forecast period. For instance, according to the World Health Organization report 2020, cancer was the leading cause of death in the world, accounting for around ten million deaths in 2020 worldwide. In terms of new cancer cases worldwide, the most common were: 2.26 million cases of breast cancer, 2.21 million cases of lung cancer, 1.4 million cases of prostate cancer, 1.20 million cases of skin cancer, 1.93 million cases of coon & rectum cancer, and 1.09 million cases of stomach cancer. According to the American Cancer Society 2020 report, around 1.8 million new cancer cases were diagnosed and 606,520 deaths by cancer in the U.S. in 2020 were reported.

Electroporation Instruments Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 232.19 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 4.4% 2030 Value Projection: US$ 328.53 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Systems, Accessories (Electrodes, Cuvettes, Chambers, Kits, Others)
  • By Application: Protein Production, Drug Delivery, Biomedical Research, Gene Therapy, Ablation (Oncology, Cardiology, Others), Others
  • By Mode: In-vitro/clinical, In-vivo
  • By End User: Biopharmaceutical Companiesompanies, Hospitals, Research & Academic Institutesnstitutes, Others
Companies covered:

Bio-Rad Laboratories, Inc, Thermo Fisher Scientific Inc., BTX ( a division of Harvard Bioscience), Celetrix, LLC., Gamma Biosciences, Merck KgaA, Eppendorf SE, MaxCyte, Inc. BEX CO.,LTD., Lonza, Altogen Biosystems, Ala Scientific Instruments, Inc., BioEra Life Sciences Pvt. Ltd., and Ichor Medical Systems

Growth Drivers:
  • Increasing cases of cancer
  • Increasing product launches and approvals
Restraints & Challenges:
  • High cost associated with electroporation instruments

Figure 2: Global Electroporation Instruments Market Share (%), by Product Type, 2022

ELECTROPORATION INSTRUMENTS MARKET

To learn more about this report, request a free sample copy

Increasing product approvals and launches are expected to drive growth of the global electroporation instruments market during the forecast period

Increasing product approvals and launches are expected to drive growth of the global electroporation instruments market during the forecast period. For instance, on April 2, 2022, Thermo Fisher Scientific Inc., an American supplier of scientific instrumentation, reagents and consumables, and software services announced the launch of Gibco CTS Xenon Electroporation System. The product is intended to enable the development of cell therapies. Moreover, on June 25, 2020, MaxCyte, a global clinical-stage cell-based medicines and life sciences company, announced the launched of the first product in its new and expanded ExPERT disposables line. The R-1000 cuvette can process a volume of up to one mL, or up to 200 million cells, and offers greater versatility for companies developing cell therapy drugs, as well as those advancing early drug discovery. These new cuvette designs can be used across the entire range of MaxCyte's electroporation instrumentation.

Global Electroporation Instruments Market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. The COVID-19 pandemic has affected the economy of various regions across the globe in three main ways; 1) by directly affecting the production and demand; 2) by creating disruptions in distribution channels; and 3) through its financial impact on companies and financial markets. Several countries such as Thailand, Indonesia, and Singapore are facing problems with regard to the transportation and distribution of healthcare products.  However, the COVID-19 pandemic might have a positive impact and boost growth of the global electroporation instruments market over the forecast period, owing to the use of electroporation in delivering vaccines and drugs for the treatment of COVID-19. For instance, according to an article published in Eureka, blog of Charles River Laboratories Inc., U.S., on January 13, 2021, as the race for a COVID-19 vaccine intensified, researchers began looking for better, more effective drug delivery systems. Electroporation is one such in vivo drug delivery technologies. It has been demonstrated that electroporation has a significant impact on vaccine immunogenicity and efficacy. This is due to the fact that it has the potential to increase antigen delivery by up to 1,000-fold when compared to naked DNA delivery technologies alone. The increase in antigen delivery results in a greater magnitude of immune response as well as higher response rates when compared to DNA delivery via direct injection alone.

Electroporation Instruments Market Restrains:

High cost associated with electroporation instruments, lack of skilled professionals, and stringent government regulations are expected to hinder growth of the global electroporation instruments market over the forecast period. According to the data published in Inverse Journal 2020, the electroporation instrument may cost in the range of US$ 3,000 to US$ 11,000

Key Players

Major players operating in the global electroporation instruments market are Bio-Rad Laboratories, Inc, Thermo Fisher Scientific Inc., BTX ( a division of Harvard Bioscience), Celetrix, LLC., Gamma Biosciences, Merck KgaA, Eppendorf SE, MaxCyte, Inc. BEX CO.,LTD., Lonza, Altogen Biosystems, Ala Scientific Instruments, Inc., BioEra Life Sciences Pvt. Ltd., and Ichor Medical Systems

 

Frequently Asked Questions

Global electroporation instruments market is estimated to be valued at US$ 232.19 Mn in 2022 and is expected to reach US$ 328.53 Mn by 2030, exhibiting a CAGR of 4.4% during the forecast period (2022-2030).

Increasing prevalence of cancer and increasing product approvals are the major factors that are expected to drive growth of the market over the forecast period.

Accessories segment is expected to hold a major market share during the forecast period

High cost associated with electroporation instruments, lack of skilled professionals, and stringent government regulations are expected to hinder growth of the market over the forecast period.

Major players operating in the market are Bio-Rad Laboratories, Inc, Thermo Fisher Scientific Inc., BTX ( a division of Harvard Bioscience), Celetrix, LLC., Gamma Biosciences, Merck KgaA, Eppendorf SE, MaxCyte, Inc. BEX CO.,LTD., Lonza, Altogen Biosystems, Ala Scientific Instruments, Inc., BioEra Life Sciences Pvt. Ltd., and Ichor Medical Systems

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo